Diagnosis and management of autoimmune hepatitis

L Muratori, AW Lohse, M Lenzi - bmj, 2023 - bmj.com
Autoimmune hepatitis is an inflammatory disease of the liver of unknown cause that may
progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment …

[HTML][HTML] Recent updates on the management of autoimmune hepatitis

A Komori - Clinical and Molecular Hepatology, 2021 - ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is an immunoinflammatory chronic liver disease with dynamic
and rather heterogeneous disease manifestations. A trend of increasing prevalence of AIH …

Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment

K Tarao, A Nozaki, T Ikeda, A Sato, H Komatsu… - Cancer …, 2019 - Wiley Online Library
Background It is well known that the incidence of developing hepatocelluler carcinoma
(HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC …

Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study

L Grønbæk, H Vilstrup, P Jepsen - Journal of hepatology, 2014 - Elsevier
Background & Aims Population-based studies of the clinical course of autoimmune hepatitis
are scarce. We conducted a nationwide study of incidence, prevalence, prognosis, and …

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

G Wang, A Tanaka, H Zhao, J Jia, X Ma… - Hepatology …, 2021 - Springer
Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· Xiong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …

Association between immunoglobulin G4–related disease and malignancy within 12 Years after diagnosis: an analysis after longterm followup

J Asano, T Watanabe, T Oguchi, K Kanai… - The Journal of …, 2015 - jrheum.org
Objective. Because it is uncertain whether immunoglobulin G4–related disease (IgG4-RD) is
associated with malignancy, we evaluated the incidence of cancer development in a large …

[HTML][HTML] Autoimmune hepatitis: 2019 update

A Tanaka - Gut and Liver, 2020 - ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease, characterized by the
elevation of aminotransferases, presence of anti-nuclear antibody or anti-smooth muscle …

Prediction of short‐and long‐term outcome in patients with autoimmune hepatitis

MM Kirstein, F Metzler, E Geiger, E Heinrich… - Hepatology, 2015 - journals.lww.com
Autoimmune hepatitis (AIH) is a chronic inflammatory disease characterized by a loss of
tolerance toward the hepatocellular epithelium. Liver transplantation (LT) represents the …

Epidemiology and surveillance of autoimmune hepatitis in Asia

T Katsumi, Y Ueno - Liver International, 2022 - Wiley Online Library
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease that mainly injures the
hepatocytes. The autoimmune disease might be involved in its aetiology, but this remains to …

Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis

A Tansel, LH Katz, HB El-Serag, AP Thrift… - Clinical …, 2017 - Elsevier
Background & Aims The risk of hepatocellular carcinoma (HCC) in patients with autoimmune
hepatitis (AIH) is unclear. We conducted a systematic review and meta-analysis of the …